Loading...
Mixed Asset Passive

RISE Healthcare Fixed Income Balanced (253290)

Update : 2025.06.13

NAV

12,091KRW

-148.3하락 (-1.21%)

Market Price per share (KRW)

12,085KRW

-160하락 (-1.31%)

※ t-1 last price

trading volume

11,293shares

AUM

KRW 14.5billion

RISE Healthcare Fixed Income Balanced (253290)

KEY POINT

Balanced ETF with both the stability of bonds and the profitability of stocks

KEY POINT

Seek to achieve stable yield of bonds and the profitability of the healthcare sector

Basic information

Download trading information

Update : 2025.06.13
ETF name(Code), Benchmark Index, Inception date, creation unit, Net Asset (KRW 0.1 billion), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name (code) Benchmark Index Inception date Creation Unit AUM (KRW)
KB RISE HealthCare Fixed Income Balanced ETF
(253290)
FnGuide HealthCare Mix Index 2016.09.23 200,000 14,509,379,055
Trustee Market Price per share (KRW) NAV Trading Volume (shares)
하나은행 12,085
※ t-1 last price
12,091 11,293
authorized participant, Liquidity provider table
Total Expense Ratio Distribution Frequency
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%) Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants Liquidity Providers
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities KB Securities, NH Investment & Securities, Samsung Securities
ETF name(Code), Benchmark Index, Inception date, creation unit, AUM(0.1 billion) (KRW), Trustee, Rule of Dividend payment, Market Price per share (KRW), iNAV per share (KRW), trading volume (share), Total Expense ratio table
ETF Name(Code) Benchmark Index
KB RISE HealthCare Fixed Income Balanced ETF

(253290)
FnGuide HealthCare Mix Index
Inception date Creation Unit
2016.09.23 200,000
AUM(0.1 billion) (KRW) Trustee
14,509,379,055 하나은행
Market Price per share (KRW) iNAV per share (KRW)
12,085
※ t-1 last price
12,091
Trading Volume (shares)
11,293
authorized participant, Liquidity provider table
Total Expense Ratio
Year 0.35% (Designated participating company : 0.001%, Collective investment : 0.309%, trust : 0.02%, General affairs : 0.02%)
Distribution Frequency
Based on the business day before the interest payment date of the stocks constituting the index in June and December (occasional payment)
Authorized Participants
KB Securities, NH Investment & Securities, Meritz Securities, Samsung Securities
Liquidity Providers
KB Securities, NH Investment & Securities, Samsung Securities

Index Introduction

The FnGuide Healthcare Balanced Index is an index consisting of stock items constituting the FnGuide Healthcare Index and three KTBs constituting the MKF 3-year KTB Index. It maintains a 7:3 ratio of bonds to stocks everyday.

View detailed index information

TOP 10 Holdings

Update : 2025-06-13
Rank , Name, proportion table
Rank Name Weight (%)
1 KTB03000-2909(24-7) 27.88
2 KTB02875-2712(24-12) 20.63
3 RISE HealthCare 12.20
4 RISE KTB 8.52
5 KTB03250-2706(24-4) 6.92
6 원화예금 4.27
7 F 202506 2.92
8 Alteogen 2.38
9 SAMSUNG BIOLOGICS 1.93
10 Celltrion 1.75

proportion by sectors

*The proportion of investment stocks

Update : 2025.06.13
Rank , Name, proportion table
Rank Name Weight (%)
1 Healthcare 100.00

Dividend payment data

· Payable date of dividend payment 3 years.
Rule of Dividend payment, Payable date of dividend payment, dividend per share (KRW) table
Rule of Dividend payment Payable date of dividend payment dividend per share (KRW)
2025-06-09 2025-06-11 50
2024-12-09 2024-12-11 90
2024-06-07 2024-06-11 40
2023-12-08 2023-12-12 110
2023-06-08 2023-06-12 40
2022-12-08 2022-12-12 91
2022-06-09 2022-06-13 16
2021-12-09 2021-12-13 11

Performance

performance

excel download

Update : 2025-06-13

 (as of Oct : %)

The result of above Net Asset Value performance is the rate of return assuming distribution reinvestment.

classification, 1Month, 3Month, 6Month, 1year, 3year, YTD (Year to date), Since inception, NAV, Benchmark Index, Outperformance table
classification 1Month 3Month 6Month 1year 3year YTD
(Year to date)
Since
inception
NAV 1.11 -0.26 1.33 6.53 16.09 1.00 25.95
Benchmark Index 1.16 0.11 1.79 8.06 19.98 1.57 33.20
Outperformance -0.05 -0.37 -0.46 -1.54 -3.9 -0.58 -7.26

daily Performance

excel download

date, market price (KRW), NAV (KRW)
date Market price (KRW) NAV (KRW)
closing price Daily Return(%) closing price Daily Return(%)
2025.06.13 12,085 -1.306하락 12,091.15 -1.211하락
2025.06.12 12,245 - 12,239.45 0.022상승
2025.06.11 12,245 0.781상승 12,236.7 0.339상승
2025.06.10 12,150 0.041상승 12,195.34 0.436상승
2025.06.09 12,145 0.788상승 12,142.28 0.690상승
2025.06.05 12,050 -0.618하락 12,057.94 -0.061하락
2025.06.04 12,125 0.206상승 12,065.37 -0.376하락
2025.06.02 12,100 0.414상승 12,110.58 0.170상승
2025.05.30 12,050 -0.082하락 12,089.28 0.203상승
2025.05.29 12,060 0.124상승 12,064.76 0.253상승
2025.05.28 12,045 -0.165하락 12,034.23 -0.249하락
2025.05.27 12,065 0.751상승 12,064.38 0.265상승
2025.05.26 11,975 -0.083하락 12,032.39 0.310상승
2025.05.23 11,985 -0.374하락 11,994.42 -0.355하락
2025.05.22 12,030 -0.124하락 12,037.16 -0.020하락
2025.05.21 12,045 0.668상승 12,039.65 0.655상승
2025.05.20 11,965 0.419상승 11,961.19 -0.009하락
2025.05.19 11,915 -0.708하락 11,962.3 -0.328하락
2025.05.16 12,000 -0.083하락 12,001.05 -0.212하락
2025.05.15 12,010 - 12,026.55 -0.038하락

Holdings

Name, Ticker, Number. of shares, Weight(%), market price (KRW)
No. (Number) Name Ticker Number of shares Weight(%) Market price (KRW)
1 KTB03000-2909(24-7) KR103501GE98 666,666,666 27.88 682,577,999
2 KTB02875-2712(24-12) KR103501GEC6 500,000,000 20.63 505,102,000
3 RISE HealthCare KR7253280002 20,641 12.2 298,572,065
4 RISE KTB KR7114100001 1,900 8.52 208,496,500
5 KTB03250-2706(24-4) KR103501GE64 166,666,667 6.92 169,313,167
6 원화예금 KRD010010001 104,451,976 4.27 104,451,976
7 F 202506 KR4165W60005 0.67 2.92 71,446,702
8 Alteogen KR7196170005 142 2.38 58,291,000
9 SAMSUNG BIOLOGICS KR7207940008 46 1.93 47,334,000
10 Celltrion KR7068270008 261 1.75 42,777,900
11 Yuhan KR7000100008 378 1.67 40,975,200
12 HLB KR7028300002 629 1.37 33,588,600
13 PharmaResearch KR7214450009 55 1.18 28,765,000
14 SKBP KR7326030004 242 0.92 22,627,000
15 SCD KR7000250001 124 0.86 20,956,000
16 HanmiPharm KR7128940004 56 0.72 17,584,000
17 SKBS KR7302440003 235 0.45 11,056,750
18 CLASSYS KR7214150005 155 0.39 9,517,000
19 SEEGENE KR7096530001 284 0.39 9,485,600
20 ST Pharm KR7237690003 112 0.38 9,296,000
21 Celltrionph KR7068760008 178 0.37 9,060,200
22 HANALL BIOPHARMA KR7009420001 313 0.35 8,513,600
23 MedyTox KR7086900008 48 0.33 8,126,400
24 Hanmi Science KR7008930000 180 0.29 7,011,000
25 GC Corp KR7006280002 49 0.27 6,688,500
26 DAEWOONG PHARM KR7069620003 40 0.27 6,500,000
27 CHONGKUNDANG KR7185750007 76 0.27 6,688,000
28 HK inno.N KR7195940002 126 0.23 5,670,000
29 Pharmicell KR7005690003 496 0.23 5,713,920
30 CHA Biotech KR7085660009 473 0.21 5,259,760
31 Daewoong KR7003090008 174 0.19 4,645,800
32 HLBPHARMA KR7047920004 240 0.19 4,610,400
33 Binex KR7053030003 255 0.18 4,429,350
34 DENTIUM KR7145720009 58 0.16 4,019,400
35 WONTECH KR7336570007 381 0.16 4,038,600
36 EuBio KR7206650004 275 0.15 3,550,250
37 SD Biosensor KR7137310009 316 0.15 3,728,800
38 DongKook Pharm KR7086450004 206 0.15 3,687,400
39 SELVAS AI KR7108860008 210 0.13 3,276,000
40 i-SENS KR7099190001 186 0.13 3,135,960
41 BIONEER KR7064550007 197 0.13 3,195,340
42 Boryung KR7003850005 331 0.12 2,949,210
43 JWPHARMA KR7001060003 118 0.12 2,832,000
44 BioPlus KR7099430001 352 0.11 2,590,720
45 T&L KR7340570001 41 0.11 2,587,100
46 Donga ST KR7170900005 43 0.09 2,109,150
47 GC CELL KR7144510005 70 0.06 1,554,000
48 Aprogen KR7007460009 1,324 0.04 951,956
Investment notice
- The information provided on this website is based on reliable sources, but its accuracy and completeness are not guaranteed.
- Financial investment products are not protected by the Korea Deposit Insurance Corporation in accordance with the Depositor Protection Act, and a loss of investment principal may occur, which belongs to the investor.
- Past performance does not guarantee future profits.
- In the case of a collective investment scheme that invests in foreign securities, asset values may be lost due to risks caused by market, political, and economic conditions in the target country.
- Derivatives may lose all or a significant portion of the investment principal in a short period of time due to high price volatility, and there is a risk that the counterparty may not be able to fulfill the terms of the contract when investing in over-the-counter derivatives.
- Before investing, be sure to read the investment prospectus and contract recommendation document regarding the investment subject, redemption method, and fee.